Imunon (IMNN) EBT Margin (2017 - 2022)
Imunon's (IMNN) quarterly EBT Margin came in at 8860.63% in Q4 2022, down 2139834.0% YoY from N/an in Q4 2021, and down 79.45% on a QoQ basis from 4937.63% in Q3 2022.
Imunon (IMNN) EBT Margin (2017 - 2022) Analysis & Trends
Imunon (IMNN) has 6 years of EBT Margin data on file, last reported at 8860.63% in Q4 2022.
- Quarterly EBT Margin fell 2139834.0% year-over-year to 8860.63% in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 5863.11% (down 578981.0% YoY) and the FY2022 annual result came in at 7493.05%, down 306251.0% from the prior year.
- EBT Margin fell to 8860.63% in Q4 2022, from 4937.63% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 23336.77% in Q4 2018 to a low of 8860.63% in Q4 2022.
- A 5-year average of 979.25% and a median of 4125.6% in 2019 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2018 — EBT Margin soared 2703575 bps — and 2020, when it plunged 2617673 bps.
- Tracing IMNN's EBT Margin over 5 years: stood at 23336.77% in 2018, then decreased by 3 bps to 22642.18% in 2019, then plunged by 116 bps to 3534.55% in 2020, then surged by 455 bps to 12537.7% in 2021, then tumbled by 171 bps to 8860.63% in 2022.
- The last three EBT Margin figures came in at 8860.63% (Q4 2022), 4937.63% (Q3 2022), and 4870.63% (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Imunon | 8.16 Mn | 8.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -8,860.63% |
| Sep 30, 2022 | -4,937.63% |
| Jun 30, 2022 | -4,870.63% |
| Mar 31, 2022 | -4,783.56% |
| Dec 31, 2021 | 12,537.70% |
| Sep 30, 2021 | -4,165.71% |
| Jun 30, 2021 | -4,234.38% |
| Mar 31, 2021 | -4,430.84% |
| Dec 31, 2020 | -3,534.55% |
| Sep 30, 2020 | -3,685.98% |
| Jun 30, 2020 | -4,071.60% |
| Mar 31, 2020 | -4,013.61% |
| Dec 31, 2019 | 22,642.18% |
| Sep 30, 2019 | -4,496.61% |
| Jun 30, 2019 | -4,620.46% |
| Mar 31, 2019 | -4,085.49% |
| Dec 31, 2018 | 23,336.77% |
| Sep 30, 2018 | -3,411.34% |
| Jun 30, 2018 | -6,439.64% |
| Mar 31, 2018 | -3,459.09% |